Gynecological Cancer Clinical Trial
Official title:
The Effectiveness of Anti-resistance Exercise on Lower Limb Lymphoedema Among Gynecological Cancer
Background: The incidence of lower limb lymphedema (LLL) after gynecological cancer surgery with lymphadenectomy is about 10-46%. Lower limb lymphedema results in limited physical mobility and reduced patients' quality of life. A hospital -based complete decongestive therapy has been recommended to patients with LLL, including exercise, manual lymphatic drainage, compression therapy, and skin care. However, the inconvenience of the hospital-based rehabilitation program limit the availability for those patients LLL. Home-based exercise program may be feasible instead of the hospital-based program. Few studies have evaluated the effectiveness of the home-based lower extremity exercise on reliving LLL and improving quality of life in patients with LLL. Research Purposes: The main purpose of the study is to evaluate the effectiveness of a home-based exercise program for relieving lower extremity lymphedema, including circumference measurement, bioimpedance spectroscopy (BIS), lower limb muscle strength, quality of life related to cancer & LLL, and fatigue. Methods: This study is a two- year project with a single-blind randomized clinical trial. The participants are women with gynecological cancer surgery, aged of 20-75 years and currently have lower extremity lymphedema. A sample of 76 participants will be stratified randomly assigned to an experimental group or a control group. The experimental group is to carry out a home-based anti-resistance exercise with elastic band other than a routine care of complex decongestive physiotherapy; while the control group is to carry out a routine care of complex decongestive physiotherapy. The home-based program is a 12-week exercise program. Data collections will be conducted before exercise (Baseline), during exercise (second months), and exercise program after completion. Measures includes (1) Physical examination: limb leg circumference measurement, bioimpedance spectroscopy (BIS), lower limb muscle strength, (2) Questionnaires: Functional status of lymphatic edema of LLL, fatigue, and EORTC-QLQ-C30. Anticipated Outcomes: Findings from this study could provide a reference of home-based exercise guideline and be integrated into the care of activities for women following gynecological surgery with LLL.
Status | Not yet recruiting |
Enrollment | 100 |
Est. completion date | December 31, 2023 |
Est. primary completion date | December 31, 2022 |
Accepts healthy volunteers | No |
Gender | Female |
Age group | 20 Years to 75 Years |
Eligibility | Inclusion Criteria: - women with gynecological cancer surgery - aged of 20-75 years - currently have lower extremity lymphedema. Exclusion Criteria: - heart failure - kidney failure - DVT - limb surgery |
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
National Cheng Kung University |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Limb circumference change from baseline to 3 months | Measuring by measuring tape | from baseline to 3 months | |
Primary | Edema change from baseline to 3 months | Measuring by Bioelectrical Impedance Spectroscopy (BIS)- InBody S10 | from baseline to 3 months | |
Primary | Lower limb muscle strength change from baseline to 3 months | Measuring by microFET 2 | from baseline to 3 months | |
Primary | Functional status of lymphatic edema of LLL change from baseline to 3 months | Measuring by Lymphoedema Functioning, Disability and Health Questionnaire for Lower Limb Lymphoedema (Lymph-ICF-LL). It is a 28-item, 0(no problem) to 10(very severe) questionnaire. | from baseline to 3 months | |
Primary | Fatigue change from baseline to 3 months | Measuring by Chinese Lee Fatigue Scale Short Form (C-LESSF). It is a 7-item, from 0(no fatigue) to 10(very fatigue) questionnaire. | from baseline to 3 months | |
Primary | EORTC-QLQ-C30 | Measuring by EORTC QLQ C30. It is a 30-item, from 0(no problem) to 10(very severe) questionnaire. | from baseline to 3 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03935698 -
Physiotherapy Treatment in Women With Dyspareunia Following Gynecological Cancer: a Pilot Study
|
N/A | |
Completed |
NCT01831089 -
Phase I Study of Lurbinectedin (PM01183) in Combination With Paclitaxel, With or Without Bevacizumab, in Selected Advanced Solid Tumors
|
Phase 1 | |
Completed |
NCT01703585 -
Feasibility Study of Genomic Profiling Methods and Timing in Tumor Samples
|
||
Completed |
NCT04694508 -
Intraoperative Music Therapy in Gynecological Oncology
|
N/A | |
Recruiting |
NCT03714581 -
Laser Therapy Following Radiotherapy for Gynecological Cancer
|
N/A | |
Recruiting |
NCT03740503 -
Genomic Investigation of Unusual Responders
|
||
Completed |
NCT02169908 -
Analysis of Chronic Neuropathic Pain Markers in Patients Treated With Oxaliplatin
|
N/A | |
Recruiting |
NCT05028504 -
A Phase II Study of Anlotinib Combined With Penpulimab in Subjects With Gynecological Cancer
|
Phase 2 | |
Completed |
NCT02026687 -
Recovery and Analgesia After Surgery for Gynecological Cancer
|
Phase 4 | |
Not yet recruiting |
NCT06039306 -
Perioperative Immunonutrition Under Enhanced Recovery After Surgery
|
N/A | |
Active, not recruiting |
NCT04341480 -
The Safety of Chemotherapy for Patients With Gynecological Malignancy in High-risk Region of COVID-19
|
||
Recruiting |
NCT04236362 -
A Study of TQB2450 Combined With Anlotinib in Subjects With Gynecological Cancer
|
Phase 1/Phase 2 | |
Recruiting |
NCT02906943 -
Ontario-wide Cancer TArgeted Nucleic Acid Evaluation
|
||
Completed |
NCT03553784 -
Low-Intensity CBT for Gynaecological Cancer Survivors
|
N/A |